HAEMORRHAGE AND CIRCULATORY SHOCK

Published on 21/06/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1771 times

14

HAEMORRHAGE AND CIRCULATORY SHOCK

Introduction

Blood volume in the textbook subject is of the order of 5 L (see Chapter 1) and at any one time about 65% of this volume is in the venous compartment of the circulation. A reduction in blood volume may occur in many ways. Loss of whole blood through blood vessel trauma either directly out of the subject or into other tissues such as the lumen of the stomach or a thigh muscle is referred to as haemorrhage. However, excessive vasodilatation of peripheral blood vessels will induce similar physiological responses to loss of blood volume. These processes increase the ‘volume’ of the circulatory system whilst the volume of blood it contains remains unchanged leading to a relative hypovolaemia.

Normal physiological compensatory responses will usually cope with low levels of blood loss (up to 10% blood volume) without problem. This happens frequently on a voluntary basis with people who lose 500 mL blood while attending a blood donor session. The fundamentals of these physiological responses are firstly short-term maintenance of arterial blood pressure so that tissue perfusion is sustained and, secondly, over a longer time course, the lost blood volume is replaced. These mechanisms, which link together many of the individual topics covered in greater detail earlier in this book, will now be reviewed. Severe insults to the circulatory system lead to the syndrome of circulatory shock. This topic is discussed at the end of this chapter. A case history of a patient who has suffered a haemorrhage is shown in Case 14.1:1.

Case 14.1   Haemorrhage and circulatory shock: 1

Gastrointestinal bleed

Linda Hamilton is 50 years old and has suffered from mild rheumatoid arthritis for 8 years. Her symptoms are managed with diclofenac 50 mg twice a day (an NSAID with analgesic and anti-inflammatory actions). She has not been troubled with major joint disruption. Over the last 3 weeks she has noted an occasional darkening of her stools. One morning she woke feeling normal but after breakfast became quite light headed. She then suffered some abdominal discomfort and felt slightly anxious. During the late morning she developed a violent abdominal cramp and had an intense urge to defaecate. The stools she passed were dark and extremely offensive.

She called her GP for advice and she immediately advised Mrs Hamilton to call an ambulance and go to A&E. The GP explained that Mrs Hamilton may be bleeding into her gut from an ulcer. (This is a well recognized side effect of NSAIDs.)

Whilst waiting for the ambulance to arrive Mrs Hamilton began to feel more unwell. She became nauseous and, whilst in the ambulance, vomited a considerable amount of altered blood. The paramedics checked her pulse and blood pressure. Her heart rate was 115 bpm and her blood pressure 128/85 mm Hg. Her peripheries were cool and capillary refill time was 4 seconds. The paramedics inserted a large bore cannula into a vein in her arm and gave her 500 mL of Gelofusine. Her heart rate settled slightly to 95 bpm and she described feeling less unwell.

While she is still in the ambulance the following questions arise:

Arterial blood pressure changes in response to haemorrhage

Rapid (time course in minutes) blood volume losses of the order of 5–10% in someone with normally functioning circulatory reflexes produce little if any change in mean arterial pressure. A rapid 15–20% haemorrhage will cause a modest reduction in mean arterial pressure from a normal textbook value of about 93 mm Hg (see Chapter 9) to about 80–90 mm Hg. Recovery from such a haemorrhage using normal physiological mechanisms should be uneventful. A 20–30% blood volume loss might typically result in a drop in mean arterial blood pressure to 60–80 mm Hg and generate some indications of shock responses but such a haemorrhage would not normally be fatal. A blood volume loss of 30–40% however would lead to a substantial reduction of mean arterial blood pressure to 50–70 mm Hg with serious shock responses which may become irreversible. Blood volume loss beyond 50% would normally be fatal.

The fundamental links between blood loss and hypotension are described in Chapter 4 and are summarized in Figure 14.1. Decreased blood volume leads to decreased right atrial pressure and consequently decreased filling of the right ventricle. This leads to a decrease in stroke volume (Starling’s law) and therefore to a reduction in cardiac output. A 20% reduction in blood volume would typically result in an initial reduction in resting cardiac output from about 5 L/min to about 3 L/min. As mean arterial pressure is the product of cardiac output and peripheral resistance there is a fall in blood pressure as identified above. An important first aid point is that it is inadvisable to prop up someone who has suffered a haemorrhage to a sitting position. This would only further reduce the preload effects on the heart.

The compensatory responses which would help to restore blood pressure are triggered by the cardiovascular reflexes discussed in Chapter 10. Of prime importance is the carotid sinus baroreceptor reflex. The modified nerve endings which constitute the baroreceptor become less stretched as blood pressure falls. Fewer action potentials will therefore pass up the glossopharyngeal nerve and enter the brain at the level of the medulla. Following central processing of the baroreceptor input there will be activation of sympathetic outflow and inhibition of the parasympathetic nerve supply to the heart. The consequences are an increased heart rate (tachycardia) and an increase in cardiac contractility, both of which contribute to a raised cardiac output despite decreased preload effects on the heart (see Chapter 4). Re-establishment of a normal resting stroke volume as a result of a sympathetically induced increase in cardiac contractility is illustrated in Figure 14.2. In otherwise normal subjects, a significant tachycardia does not occur until the blood loss has exceeded 700–800 mL (10–15%).

Sympathetic nervous system activation also leads toα-receptor-mediated vasoconstriction (see Chapter 9). The regions of the circulation which are particularly affected by sympathetic vasoconstriction responses include the skin, gut, kidney and skeletal muscle. The brain and coronary circulations are relatively preserved especially during the sequel to a haemorrhage amounting to about 20% or less blood volume loss. Concurrent sympathetically mediated venoconstriction will help to maintain central venous pressure and hence limit the fall in preload on the right side of the heart. An unfortunate practical aspect of this venoconstriction is that it may hinder attempts to gain access to the circulation with a venous cannula so that infusion of blood or other replacement body fluids can commence.

The patient who has suffered a haemorrhage and has therefore activated these compensatory responses appears pallid due to cutaneous vasoconstriction, with cold clammy skin, possibly with peripheral cyanosis, and a weak rapid pulse. The responses to haemorrhage will vary considerably between individuals depending on factors such as age and gender, nutrition and fluid balance, season of the year and environmental temperature as well as less easily defined individual characteristics. The extent and speed of the haemorrhage will be important as well. When haemorrhage reaches levels of the order of 25–35% blood loss the sympathetic activation outlined above is succeeded by inhibition of sympathetic outflow and progression to circulatory shock as described later in this chapter. Peripheral cyanosis (see Chapter 1) is associated with a reduced local blood flow and hence greater than normal extraction of oxygen from the remaining blood. Sweating is regulated by the sympathetic nervous system and so is another manifestation of the baroreceptor reflex. Some of these autonomic nervous system mediated changes feature in the case history of Linda Hamilton outlined in Case 14.1:1. A simple but quite effective test of peripheral circulatory function is the nail capillary refill test. Pressure is applied to a finger nail bed until it has blanched. This indicates that blood has been forced away from the area. When pressure is removed the time taken for blood to return to the nail bed (indicated by a change in colour) is measured. Normally capillary refill time will be less than 2 seconds. A longer time indicates reduced tissue perfusion. This test is particularly useful in children as other signs of imminent circulatory collapse appear relatively late.

Short-term responses which help to restore lost blood volume

In Chapter 11 the ‘Starling forces’ which determine the movement of water across capillary walls are described. Fundamentally, the capillary blood pressure (hydrostatic pressure) tends to move water out of the capillary bed into the interstitial fluid. This is opposed by a gradient of colloid osmotic pressure which will tend to draw water from the interstitial compartment back into the capillary.

Following a haemorrhage, there may be a fall in mean arterial pressure but, in addition, a compensatory peripheral vasoconstrictor response occurs. As the main resistance vessels (see Chapter 9) are the arterioles, vessels which come immediately before the capillaries, there will be a fall in capillary blood pressure following a haemorrhage. This will alter the balance of the Starling forces and, as the colloid osmotic pressure of plasma is initially unchanged, this will result in a net movement of water from the interstitial space into the blood. This is illustrated in Figure 14.3. The rate and extent of this internal replacement of lost blood volume will depend on the rate and degree of blood loss. A rapid loss of 20% of blood volume (about a 1000 mL haemorrhage in the ‘textbook person’) will lead to perhaps 600 mL of interstitial fluid entering the blood over a period of around 10 minutes. This is sometimes referred to as an ‘internal transfusion’. As skeletal muscle constitutes about 50% of body weight this tissue is a major source of the interstitial fluid for the internal transfusion.

Case 14.1   Haemorrhage and circulatory shock: 2

A deterioration in Linda’s condition

Just as the ambulance arrives at the hospital Mrs Hamilton vomited again. This time about 1.5 L of fresh blood was produced. Mrs Hamilton became agitated and the paramedics set-up another 500 mL of Gelofusine whilst rushing her into the Resuscitation Room. The A&E staff repeated Mrs Hamilton’s observations; her pulse was now 136 bpm and weak. Blood pressure had fallen to 73/25 mm Hg. She responded to commands but was not coherent. Her peripheries were cold and clammy. Her capillary refill time was greater than 6 seconds.

The resuscitation team inserted a second large bore cannula and continued to give IV fluid. O negative blood was given whilst the blood taken from the second cannula was sent for basic full blood count, biochemistry, clotting and cross-match of 5 units. Her initial [Hb] came back at 64 g/L (normal range for a woman: 115–160 g/L).

After 2 units of O negative blood and 2 L of 0.9% saline (normal saline) Mrs Hamilton was responsive. However she remained tachycardic (pulse 106 bpm beats per minute) and hypotensive (blood pressure 102/65). She was catheterized soon after arrival in the hospital and her urine output remained low at around 1 mL/kg/h.

The following questions arise concerning the status of Linda’s circulatory system at this time.

A further factor which helps to maintain the internal transfusion is hormonally driven glycogen breakdown in the liver (Fig. 14.3). Sympathetic activation and an associated increase in adrenaline (epinephrine) secretion from the adrenal medulla lead to release of glucose from glycogen stores and, as a consequence, an increase in plasma and interstitial fluid osmolarity. More than half of total body water is held inside cells (see Chapter 11) and the rise in osmolarity draws fluid into the interstitial space from the intracellular compartment. It has been estimated that this fluid movement from the intracellular compartment contributes about half of the volume of the internal transfusion.

The colloid osmotic pressure of plasma will gradually fall as a result of dilution with interstitial fluid. At the same time, capillary blood pressure will gradually rise back towards normal levels as a result of the internal transfusion. Eventually a new equilibrium will be established between the Starling forces and so the internal transfusion will cease.

A consequence of the internal transfusion is haemodilution, a fall in haematocrit. Many patients who have suffered a haemorrhage will already have a low haematocrit by the time they reach hospital. While on the one hand this reduced haematocrit will lower blood viscosity (see Chapter 8) and make it easier for blood to flow round the body, the reduced viscosity also lowers the resistance to blood flow and potentially contributes to a further fall in blood pressure. The reduced oxygen carrying capacity of blood as a result of haemodilution will restrict oxygen delivery to already poorly perfused tissues.

Longer term responses which help to restore lost blood volume and electrolytes

Shifting water between the various fluid compartments in the body as a short-term measure still leaves the problem of replacing the overall water loss following a haemorrhage. This is achieved by a combination of changes in glomerular filtration rate in the kidneys and hormonally mediated changes in kidney tubular function (Fig. 14.4). Assuming an adequate oral salt and water intake, in the case of a 20% blood volume loss the body fluid volumes would be returned to normal over a period of about 3 days.

Sympathetic activation, as a result of the fall in blood pressure and the baroreceptor reflex, leads to intrarenal vasoconstriction. This particularly affects the afferent arterioles but also the efferent arterioles at the glomeruli. This leads to a reduction in glomerular filtration rate which helps to conserve water and electrolytes. The potential danger of prolonged intrarenal vasoconstriction is ischaemia leading to acute tubular necrosis (ATN). The nephron becomes blocked with swollen and necrotic tubular epithelial cells and the patient becomes oliguric (less than 100 mL urine per day). ATN is recoverable provided volume replacement is achieved and glomerular function is re-established within an adequate time course.

The main hormones involved in salt and water retention are described below.

Renin-angiotensin aldosterone system (see Chapter 9)

The main triggers for increased renin release following haemorrhage are firstly an increase in sympathetic nerve activity which, via a β-adrenoceptor mechanism on the juxtaglomerular (JG) cells, will increase renin secretion (Fig. 14.4). This increase in renin secretion is therefore linked to the fall in blood pressure at the carotid sinus baroreceptor. Secondly, the JG cells respond directly to a fall in renal artery blood pressure to increase renin secretion. An increase in renin secretion will increase the generation of angiotensin II (Ang II). This has two beneficial roles in the acute response to haemorrhage. The immediate vasoconstrictor effect of Ang II helps to maintain arterial blood pressure. Ang II is also the major stimulus to increased aldosterone synthesis in the zona glomerulosa of the adrenal cortex.

Aldosterone has a sodium retaining and potassium excreting action on the distal segments of the nephron. Water is absorbed osmotically along with the sodium retained. Ang II is also involved, by its action on the subfornical organ of the brain, in promoting thirst responses. A patient who had suffered an acute 20% haemorrhage and has had no fluid replacement therapy would experience an intense thirst within an hour or so. This is mainly due to changes in the environment of the thirst centre in the hypothalamus associated with the fluid shifts which generate the internal transfusion (see p. 164).

Natriuretic peptide hormones (ANP and BNP)

Release of these hormones, particularly from the atria of the heart, is an important aspect of normal blood volume regulation (Fig. 14.4). Expansion of blood volume with the consequent increase in central venous pressure and increased stretch of the right atrial wall is the normal trigger for release of natriuretic peptides. Actions of natriuretic peptides include inhibition of the action of aldosterone and a vasodilator action, especially within the kidney, which increases GFR. Following a haemorrhage, natriuretic peptide hormone levels will be suppressed as a consequence of the reduction in central venous pressure. The sodium and water losing effects of the peptides will be reduced thus contributing to maintaining the extracellular fluid volume.

Antidiuretic hormone (ADH)

This peptide hormone is synthesized in the hypothalamus and released into the circulation from the posterior pituitary (Fig. 14.4). The major physiological triggers for secretion are a fall in blood volume, detected by stretch receptors in the atria and great veins (see Chapter 10), or a rise in the osmolarity of blood passing through the hypothalamus. ADH secretion will therefore be increased following haemorrhage.

ADH was initially named vasopressin in recognition of the vasoconstrictor actions of the hormone. Following a haemorrhage high levels of the hormone will contribute to the rise in peripheral resistance, particularly in the cutaneous circulation of the face. These are minor effects compared to sympathetically mediated vasoconstriction however.

The antidiuretic actions of ADH result from an increase in the water permeability of the inner medullary collecting duct of kidney tubules. This allows increased osmotically driven water reabsorption in this segment of the nephron and therefore a reduction in urine volume. Patients who have suffered a haemorrhage have a reduced urine flow rate and are said to be oliguric if their urine flow rate is less than 400 mL/day. In an adult the term anuria is used if urine flow rate is less than 50 mL/day.

Replacement of the remaining components of the lost blood volume

Following the ‘internal transfusion’ and the activation of salt and water retention in the kidneys the remaining plasma proteins and red blood cells in the circulation are diluted. Plasma proteins are mainly synthesized in the liver and increased synthesis leads to replenishment within about 1 week of a moderate haemorrhage.

Red blood cell production occurs in the bone marrow under the control of the kidney hormone erythropoietin (Epo). The reduced red cell mass and hence reduced oxygen carriage after a haemorrhage is detected within the kidney and results in increased Epo production. The red cells lost during a 20% haemorrhage are replaced in about 4–6 weeks.

Case 14.1   Haemorrhage and circulatory shock: 3

A successful resolution of Linda’s problems

Linda was transferred to a high dependency care unit where she underwent a further decompensation. She was resuscitated with 2 units of cross-matched blood and 1 L of normal saline. It was felt that her condition was not fully satisfactory and an urgent surgical consultation was requested. She was further stabilized and then taken for emergency laparotomy which resulted in the successful repair of a bleeding duodenal ulcer.

The following questions arise:

Decompensated or irreversible shock following haemorrhage

The events described above constitute the compensatory responses to haemorrhage. Most normal people can recover from the loss of up to about 25% of blood volume by purely physiological responses, although clinical intervention will accelerate recovery and minimize end-organ damage. If the blood loss exceeds about 30% of total blood volume and there is a delay of more than 3–4 hours before volume replacement therapy commences, the patient may enter the syndrome of decompensated or irreversible shock. Subsequent full restoration of blood volume may be to no avail.

An increase in sympathetic nervous system activity helping in various ways to sustain arterial blood pressure as described above is a key feature of the compensatory responses to haemorrhage. Decompensation is associated with a fall in arterial blood pressure as a consequence of substantial peripheral vasodilatation. This follows a reduction in sympathetic vasoconstrictor activity which originates in the central pathways in the brain which control sympathetic outflow. Circulating levels of vasoconstrictor hormones such as Ang II, vasopressin and catecholamines remain high but are unable to counter the fall in sympathetic activity. This phase is associated with bradycardia.

The decline in blood pressure has an adverse effect on cardiac function with reduced coronary perfusion. This results in a dangerous positive feedback loop as the fall in cardiac output will lead to further reduction in blood pressure and therefore further impaired coronary blood flow and hence further reduced cardiac performance. The poor tissue perfusion also has an adverse effect in peripheral tissues as it leads to local metabolic acidosis. Accumulation of tissue metabolites, such as H+ (see Chapter 9), leads to vasodilatation and a further reduction in arterial blood pressure.

Decompensated shock represents a downward spiral of events which may be difficult to interrupt. The general principles of circulatory failure management are firstly to ensure adequate lung ventilation and provide extra oxygen, secondly to restore blood volume by infusion of blood or other fluids and thirdly to use interventions which improve cardiac performance. Experts in this area sometimes refer to the ‘golden hour’. Optimal management of haemorrhage within this window of opportunity is crucial for minimizing morbidity and mortality. Correct recognition of the signs and symptoms of reversible shock helps to avoid the onset of catastrophic circulatory collapse.

Causes of shock

Physiological shock is the failure to provide end organs with adequate nutrients. Shock can be conveniently considered under four main headings:

In each case tissue perfusion is reduced and there is an inadequate supply of oxygen to the tissues.

Changes in the body which follow a haemorrhage (hypovolaemic shock) have been outlined above. It should be stressed that there is considerable variation in the responses between different individuals. The prognosis for individuals who suffered identical haemorrhages may be quite different.

In cardiogenic shock following events such as myocardial infarction (see Chapter 5) or serious arrhythmias there will be a fall in systemic arterial blood pressure as a result of the fall in cardiac output. In contrast to hypovolaemic shock, central venous pressure and pulmonary vein pressure are both likely to be increased. Poor left ventricular performance will lead to a rise in filling pressure on the left side of the heart and the possibility of pulmonary oedema. Fluid replacement therapy must therefore be very carefully managed. The changes in kidney function, which are primarily triggered by the fall in arterial blood pressure, will be broadly similar in haemorrhagic and cardiogenic shock.

Septic shock is a common cause of distributive shock and may be associated with bacterial, viral, fungal or protozoal infections. These infections may lead to the release of a wide range of toxic mediators which cause cell damage and cell death. Septic shock represents a complex series of events which may be collectively referred to as the systemic inflammatory response syndrome (SIRS). In the initial phases of septic shock, there is peripheral vasodilatation and a high cardiac output with excess peripheral perfusion and adequate urine flow rate. Later stages of septic shock are associated with vasoconstriction and a fall in cardiac output as a result of increased production of vasoconstrictor agents such as Ang II, catecholamines and thromboxanes. Treatment of the infection is a crucial part of management strategies.

Anaphylactic shock is another form of distributive shock. It represents an immediate hypersensitivity reaction which usually occurs within 30 minutes of exposure to an antigen such as a drug (e.g. penicillin), a specific protein (e.g. in a peanut) or an insect venom (e.g. a bee sting). It is mediated by immunoglobulin E (IgE) and leads to the release of mediators such as histamine which are stored in granules within mast cells. Vasodilatation and an increase in capillary permeability follow the release of histamine (see Chapter 11).

Fluid replacement therapy

The primary reason for fluid replacement therapy is to maintain tissue perfusion by ensuring an adequate cardiac output and a sufficiently high arterial blood pressure. Optimizing the preload effects on the heart in order to maintain cardiac output is an important aspect of fluid management. However care must be taken to avoid overload as this may lead to pulmonary oedema, especially if the patient is already in cardiac failure (see Chapter 6).

An extensive clinical analysis of fluid replacement therapy in a wide range of clinical conditions is outside the scope of this book but some general principles can be established. In relation to calculating the quantity of replacement body fluid the following points are relevant:

Use of blood as a replacement fluid

In the case of haemorrhage blood transfusion is preferable as soon as appropriate cross-matched blood is available. This will improve the oxygen carrying capacity of the circulation but there are a number of potential problems with blood transfusion in addition to the fundamental difficulties of cost, availability, ethical/religious considerations and potential for transmission of infection.

• Cross-matching of blood does take some time which may be critical in an emergency situation. Even then adverse immunological reactions may take place.

• Transfusion which increases the haematocrit above an optimal level of 30–35% may increase the viscosity of blood (see Chapter 8) and hence the flow characteristics may change. Old stored red cells lose part of the flexibility which is essential for them to pass through capillaries (see Chapter 11). This may contribute to the obstruction of small vessels and cause local hypoxia.

• Stored blood loses platelets and is deficient in clotting factors. This may leave the patient with reduced ability to coagulate blood, a dangerous situation particularly during surgery. An effective clotting mechanism can be restored by administering clotting factors and extra platelets.

• Citrate is used as an anticoagulant for stored blood and, as this is metabolized, a metabolic alkalosis (see Chapter 1) will develop over the next 1–2 days.

• 2,3,DPG (see Chapter 1) which is generated inside red cells disappears during storage. This means that the affinity of haemoglobin to bind oxygen increases. The red cells pick up oxygen at the lungs without problem but fail to deliver it adequately in the tissues.

• Other potential sources of problems include a low [Ca++] and high [K+] in stored blood.

Use of crystalloid solutions as replacement fluids

The term crystalloid covers a range of replacement body fluids. The two simplest solutions are 0.9% saline (9 g sodium chloride/L) and 5% dextrose (50 g glucose/L). Combinations of these two solutes in different proportions (e.g. 0.45% NaCl + 2.5% glucose) together with solutions which more closely reflect the composition of plasma by the inclusion of other constituents (e.g. Hartmann’s solution, Ringer-lacate solution) are all isotonic solutions. This means that they do not change the size of cells they come into contact with.

Hypertonic saline solutions (1.8% up to 10% saline) are available for use in special circumstances.

The characteristic of crystalloid solutions is that as the solutes are small they cross capillary walls. The volume of distribution is therefore at least all of the extracellular fluid compartment. The distribution of Na+ and Cl in body fluids is predominantly extracellular and so saline infusion will mainly expand the extracellular space. Dextrose solutions are handled differently. Once infused into the circulation the glucose will be taken up into cells and either metabolized or stored as glycogen. Giving isotonic dextrose solution is therefore ultimately equivalent to an infusion of distilled water. The difference is that there is a sufficient time delay for the solution to become distributed around the body and mix with other body fluids before the glucose is removed. There is therefore dilution of body fluids but no osmotic lysis of cells. Some of the water will enter the intracellular compartment by moving down the osmotic gradient created by the dilution of the extracellular fluid. The volume of distribution of the water is therefore the same as for total body water, i.e. two thirds intracellular and one third extracellular (see Chapter 1).

Use of colloid solutions as replacement fluids

Colloids are large molecules which are initially distributed within the plasma compartment as they are too big to escape across many capillary walls in significant amounts. Colloids in common clinical use include albumin, polygelatins, starch derivatives and dextrans. They are used to raise the colloid osmotic pressure of plasma and therefore prevent or reverse the movement of water from the plasma into the interstitial fluid. The volume of colloid solution needed in order to increase the intravascular volume and therefore the preload on the heart by a given amount will be much smaller than for a crystalloid solution.

Human albumin (rmm = 69 000) is quantitatively the most important contributor to the colloid osmotic pressure of blood. It is normally held within the vascular compartment unless capillary permeability is increased (see Chapter 11). Infusion of an isotonic solution containing human albumin can be used to increase blood volume. However the half-life of albumin in plasma is relatively short, 10% of administered albumin leaves the circulation within 2 hours and 95% within 2 days. Human albumin is used for volume replacement in shock and in burned patients but is not recommended for routine volume replacement because supplies are limited and effective cheaper alternatives are available.

Polygelatin solutions are polypeptides which have commercial names including Haemaccel and Gelofusine (rmm = 35 000) and are isotonic with plasma. They can be given safely in large volumes but, as the cut-off for the size of molecule that can pass through the glomerular filter in the kidney is about 70 000, their half-life in the circulation is only about 4 hours. Large amounts of these polygelatines passing through the nephron may cause an osmotic diuresis and therefore increase urinary fluid loss. They are useful for acute resuscitation procedures but for longer term circulatory support longer half-life colloids need to be used.

Hydroxethyl starches (HES) are highly branched glucose polymers (rmm 70 000 or 200 000) with a circulatory half-life of approximately 17 days. Some disruptions of the clotting cascade are associated with the use of HES.

Dextrans are large polysaccharide molecules (rmm40 000 or 70 000) with a circulatory half-life of 2–12 hours. They are very effective at increasing the colloid osmotic pressure of plasma but suffer from some side effects. They interfere with cross-matching of blood and a maximum recommended dose should not be exceeded because of the risk of renal failure developing. The clinical uses of dextrans are limited by the availability of alternatives. Up to 5% of patients may develop anaphylaxis.

Selection of suitable volume replacement therapy is a complex decision for which the volume and composition of the fluid lost is a prime consideration. It is also an area of considerable controversy. The relative merits of crystalloid or colloid solutions for fluid replacement during surgery and in resuscitation is a subject for heated debate.